亚洲知识产权资讯网为知识产权业界提供一个一站式网上交易平台，协助业界发掘知识产权贸易商机，并与环球知识产权业界建立联系。无论你是知识产权拥有者正在出售您的知识产权，或是制造商需要购买技术以提高操作效能，又或是知识产权配套服务供应商，你将会从本网站发掘到有用的知识产权贸易资讯。

返回搜索结果

Anti-Tuberculosis Compounds

总结: Novel Mycobacterium tuberculosis thioredoxin reductase inhibitors with antimycobacterial activity in infected macrophages that overcomes problems of current anti-tuberculotics.

技术优势: Novel class of compounds that inhibit a novel target with potential to overcome resistance problems of M. tuberculosis to other drugs
Viability of infected macrophages is not affected
Increased bioactivity by optimized permeability through the cell wall of M. tuberculosis

详细技术说明: The interaction between the mycobacterial thioredoxin reductase (TrxR) and its substrate thioredoxin (Trx) is a promising new drug target for the treatment of tuberculosis, since Mtb lacks the common glutathione system and the mycobacterial TrxR shows a substantial difference in sequence, mechanism and structure to human TrxRs. It was shown that TrxR is essential for thiol redox homeostasis and genetic inactivation in vivo eradicates Mtb during acute and chronic mouse infections. In order to further improve the bioactivity of promising compounds, researchershave focused on optimizing the physico-chemical properties that are important for permeability, since M. tuberculosis shows an unusual thick and impermeable cell wall.

分类: - international:
A61K31/47; A61K31/4709; A61P31/06; C07D215/44; C07D215/46; C07D401/12; C07D413/12
- cooperative:
C07D215/44; C07D215/46; C07D401/12; C07D413/12

欲了解更多信息，请点击这里